7 December 2024 in Neuroscience
6 January 2026 in Journal of Neuroscience Research
14 December 2022 in Neuroimmunomodulation
Introduction: Neurotensin (NTS) is a 13-amino acid neuropeptide functionally linked with the brain dopaminergic system via expression of the NTS peptide or its receptor in dopamine neurons. Neuropeptide-binding immunoglobulins (Igs) are present in humans and can be involved in both physiological and pathological processes. Considering the functional link between NTS and dopamine neurons, we studied the occurrence of NTS-binding IgG autoantibodies in patients with Parkinson’s disease (PD). Methods: Plasma levels of NTS-binding IgG were analyzed using enzyme-linked immunosorbent assay in both male and female PD patents and in age-matched healthy controls. Possible microbial origin of NTS cross-reactive IgG was analyzed by sequence alignment of the 6-amino acid C-terminal NTS pharmacophore with bacterial and viral proteins from the public NCBI database. Results: NTS-binding IgG were detected in the plasma of all study subjects, while their levels were consistently lower in PD patients versus controls (p = 0.0001), independently from age or sex of the study participants. Moreover, PD patients with a more severe stage (2.5–3.0) of the disease had lower levels of NTS-binding IgG (p = 0.0004) than those with a milder stage (1.0–2.0). Furthermore, PD patients taking amantadine or high doses of levodopa had higher levels of NTS-binding IgG than those without medication. Contiguous sequence homology for the NTS pharmacophore was present in several microbial proteins occurring in human gut microbiota. Discussion: The study revealed that NTS-binding IgG occur naturally in humans and that PD patients display their low plasma levels accentuated by disease severity. The functional significance of this finding and its relevance to the pathophysiology of PD, including putative link to gut microbiota, remain to be studied.
24 December 2024 in Medical academic journal
BACKGROUND: Modeling intrusive memories of psychologically traumatic event in post-traumatic stress disorder and assessing the development of mental disorders in the long-term period is relevant in order to understand the mechanisms of vital stress caused. Pathological anxiety may reflect the experienced feeling of fear and helplessness and intrusive traumatic memories in post-traumatic stress disorder. AIM: The purpose of the study was to assess the level of anxiety and exploratory activity of male rats in the Elevated Plus Maze test after experiencing vital stress in association with twice repeated trauma reminders in a delayed period. MATERIALS AND METHODS: The study was performed on mature male Wistar rats weighing 300–350 g (n = 34). Mental trauma was modeled by the circumstances of experiencing the situation of partner’s death from the action of a predator and the threat to their own life when placing rats in a terrarium with a tiger python. In rats, the behavior in the Elevated Plus Maze test was analyzed two months after an exposure to stress. RESULTS: In the delayed period after vital stress, the Elevated Plus Maze test showed an increase in anxiety and a decrease in exploratory activity of male rats. When placed twice in a traumatic environment, male rats with previously received psychogenic trauma maintained an increased level of anxiety and suppression of exploratory activity in the long-term period. CONCLUSIONS: Two months after vital stress, male rats show increased anxiety and reduced exploratory activity. The traumatic event reminder leads to worsening of behavioral disorders caused by psychogenic trauma, indicating a stable, long-lasting development of post-traumatic stress disorder.
5 November 2024 in Russian neurological Journal
The review summarizes and systematizes data on the prognostic significance of various biomarkers in determining the effectiveness of pathogenetic therapy for spinal muscular atrophy. The review includes a clinical case of a patient with type 3 spinal muscular atrophy. The case illustrates that a decrease in the level of heavy chains of neurofilaments in the cerebrospinal fluid of the patient during the use of pathogenetic therapy with nusinersen positively correlated with an improvement in motor function, assessed by standard functional scales.
27 October 2026 in Neurochemical Research